Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Buy
2,527
+376
+17% +$102K 0.16% 96
2025
Q4
$637K Buy
2,151
+1,147
+114% +$344K 0.15% 91
2025
Q3
$283K Sell
1,004
-424
-30% -$111K 0.07% 136
2025
Q2
$421K Sell
1,428
-318
-18% -$81.9K 0.12% 104
2025
Q1
$434K Sell
1,746
-119
-6% -$29.1K 0.14% 99
2024
Q4
$410K Sell
1,865
-86
-4% -$19.2K 0.12% 113
2024
Q3
$431K Buy
1,951
+317
+19% +$62.2K 0.14% 100
2024
Q2
$283K Buy
1,634
+119
+8% +$20.7K 0.1% 120
2024
Q1
$289K Buy
1,515
+273
+22% +$49.8K 0.11% 117
2023
Q4
$203K Sell
1,242
-5,494
-82% -$830K 0.08% 127
2023
Q3
$934K Sell
6,736
-811,726
-99% -$115M 0.46% 46
2023
Q2
$892K Buy
818,462
+811,180
+11,140% +$105M 0.41% 54
2023
Q1
$951K Sell
7,282
-169
-2% -$22.6K 0.5% 50
2022
Q4
$1.05M Buy
+7,451
New +$1.03M 0.64% 41

Other funds holding IBM

Prostatis Group's IBM Position: Q1 2026 in Review

Prostatis Group increased its IBM (IBM) stake by 17% in Q1 2026, buying an estimated $102K and bringing the position to 2,527 shares worth $612K. The position accounts for 0.16% of the portfolio, ranked #96.

Prostatis Group first reported a position in IBM in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.05M in Q4 2022. 3,464 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Prostatis Group held 2,527 shares of IBM worth $612K as of Q1 2026.
  • Prostatis Group bought 376 IBM shares in Q1 2026, an estimated $102K.
  • IBM made up 0.16% of Prostatis Group's portfolio in Q1 2026, its #96 holding.
  • Prostatis Group first reported a position in IBM in Q4 2022 and has held it in 14 quarters since.
  • Prostatis Group's IBM position peaked at $1.05M in Q4 2022.
  • 3,464 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.